BridgeMD
Compares treatment options for Guided Bone Regeneration
Official title Assessment Of Guided Bone Regeneration Using Xenograft Mixed With Allogenic Bone Graft Versus Xenograft Mixed With Autogenous Graft For Augmentation Of Maxillary Alveolar Ridges
ClinicalTrials.gov ID: NCT07367464
What this study is testing
What is Allogenic bone graft mixed with Xenograft in ratio 1:1?
Allogenic bone graft mixed with Xenograft in ratio 1:1 is an investigational medicine, given as an once-weekly pill taken by mouth, being studied as a potential treatment for guided bone regeneration.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the effect of Allogenic bone graft mixed with Xenograft in ratio 1:1, on the radiographic and histomorphometric assessment versus Autologous bone graft mixed with Xenograft in ratio 1:1 in maxillary deficient ridges، In guided bone regeneration of deficient edentulous maxillary ridges, will the application of Xenograft mixed with Allograft (1:1) be as effective as Xenograft mixed with Autogenous graft (1:1) in terms of dimensional ridge changes and Quality of newly formed bone? Evaluation of the patient's general condition of the oral cavity, to make sure it complies with the criteria required to be enrolled in the study in terms of oral hygiene and pathological conditions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Age: 20-50 years.
- Totally or partially edentulous maxillary ridges.
- Patients with insufficient bone for an implant placement.
- Residual alveolar width ranging from 2 to 4 mm.
- Minimum of 10 mm vertical dimension to nasal floor or sinus floor.
You likely can't join if
- Pathological lesions in the defect site.
- Systemic diseases that would interfere with bone metabolism. Uncontrolled diabetic patients.
- Ongoing treatment or a history of recent chemotherapy or radiotherapy.
- Patient with medical condition that contraindicates surgical procedures.
- Patients on medication that may interfere with healing (Corticosteroids, Bisphosphonate, Chemo/radio therapy).
- Patients with vertical bone deficiency.
See the full eligibility criteria
- Age: 20-50 years.
- Totally or partially edentulous maxillary ridges.
- Patients with insufficient bone for an implant placement.
- Residual alveolar width ranging from 2 to 4 mm.
- Minimum of 10 mm vertical dimension to nasal floor or sinus floor.
- Patients with healthy systemic condition (Medically free).
- Adequate inter-arch space for placement of the implant prosthetic part.
- Pathological lesions in the defect site.
- Systemic diseases that would interfere with bone metabolism. Uncontrolled diabetic patients.
- Ongoing treatment or a history of recent chemotherapy or radiotherapy.
- Patient with medical condition that contraindicates surgical procedures.
- Patients on medication that may interfere with healing (Corticosteroids, Bisphosphonate, Chemo/radio therapy).
- Patients with vertical bone deficiency.
- Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or para-functional habits.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.